๐Ÿ•ท๏ธ
SetupAI
็น
๐ŸŒStalecollected in 51m

Gestala Raises $21.6M for Ultrasound BCI

Gestala Raises $21.6M for Ultrasound BCI
PostLinkedIn
๐ŸŒRead original on The Next Web (TNW)
#funding#bci#ultrasoundgestalagestalaneuroxess

๐Ÿ’ก$21.6M for ultrasound BCIโ€”China's biggest early round signals neurotech shift.

โšก 30-Second TL;DR

What Changed

Gestala raised $21.6M early-stage funding

Why It Matters

Boosts non-invasive BCI race in China, challenging implantables and accelerating accessible neurotech for researchers and applications.

What To Do Next

Explore Gestala's ultrasound BCI docs for non-invasive neurotech integration in your research.

Who should care:Researchers & Academics

Key Points

  • โ€ขGestala raised $21.6M early-stage funding
  • โ€ขNon-invasive ultrasound BCI technology
  • โ€ขFounded by Phoenix Peng of NeuroXess
  • โ€ขChina's largest BCI seed round, oversubscribed
  • โ€ขLaunched two months before raise

๐Ÿง  Deep Insight

Background and context from public sources โ€” not the original article. 6 sources cited.

๐Ÿ”‘ Enhanced Key Takeaways

  • โ€ขGestala was co-founded by Phoenix Peng and Tianqiao Chen, founder of Shanda Group and gaming entrepreneur.[1][2]
  • โ€ขThe company is headquartered in Chengdu High-Tech Zoneโ€™s Tianfu International Bio City, with additional operations in Shanghai and Hong Kong.[1][2]
  • โ€ขGestala's initial clinical device targets chronic pain by stimulating the anterior cingulate cortex, with plans for a wearable home helmet for depression, stroke recovery, sleep disorders, and more.[1][4]
๐Ÿ“Š Competitor Analysisโ–ธ Show
FeatureGestalaMerge LabsNeuralink
InvasivenessNon-invasive ultrasoundNon-invasive ultrasoundInvasive implants
Primary FocusStimulation first, reading laterUltrasound BCIElectrical implants
Backing$21.6M seed (oversubscribed)OpenAI-backedElon Musk

๐Ÿ”ฎ Future ImplicationsAI analysis grounded in cited sources

Gestala's ultrasound BCI could accelerate clinical adoption for chronic pain treatments
Focused ultrasound for neural modulation has prior FDA approvals for conditions like Parkinson's, providing a regulatory foundation for Gestala's anterior cingulate cortex targeting.[4]
Whole-brain access via ultrasound may surpass electrical BCI limitations
Ultrasound detects blood flow changes across broader brain regions unlike implants limited to specific areas like the motor cortex, as stated by founder Phoenix Peng.[1]

โณ Timeline

2025-09
Early company news and science publications begin on Gestala website
2025-10
Multiple news announcements on Gestala website
2025-11
Gestala website news activity increases
2026-01
Peak news coverage on Gestala website leading to launch
2026-02
Official establishment of Gestalt (Chengdu) Technology Co., Ltd. as China's first ultrasound BCI company
2026-03
Gestala raises $21.6M in oversubscribed seed round
๐ŸŒRead original article on The Next Web (TNW)
๐Ÿ“ฐ

Weekly AI Recap

Read this week's curated digest of top AI events โ†’

๐Ÿ‘‰Related Updates

Same topic

Explore #funding

Same product

More on gestala

Same source

Latest from The Next Web (TNW)

Anthropic IPO Could Top $100B in Funding

Anthropic IPO Could Top $100B in Funding

cnBeta (Full RSS)โ€ขAug 22
AI-Trained Skin Predicts New Drug Compounds

AI-Trained Skin Predicts New Drug Compounds

The Next Web (TNW)โ€ขAug 22
AI Data Centres Trigger Car Component Shortages

AI Data Centres Trigger Car Component Shortages

The Next Web (TNW)โ€ขAug 22
768 Leaked AWS Keys Still Grant Dangerous Access

768 Leaked AWS Keys Still Grant Dangerous Access

The Next Web (TNW)โ€ขAug 22

AI-curated news aggregator. All content rights belong to original publishers.
Original source: The Next Web (TNW) โ†—

This is a summary, not the original. Read the source, or get the weekly briefing.

Weekly AI briefing

One email a week. Unsubscribe anytime.